Good conversations, unclear opportunities
The market is engaging, but it is difficult to distinguish curiosity from intent.
Who Narrow is for
Narrow works with founder-led deep-tech, biotech, scientific and technical B2B businesses where the product has moved beyond pure development but the commercial model is not yet repeatable.
Often the founding team’s expertise is in science, engineering, medicine, research or technology rather than sales and commercial strategy. The next stage requires a different set of disciplines.
The stage
Narrow is typically most relevant when several of these are true:
Deep-tech commercialisation
A technology can work. A pilot can succeed. A technical team can believe strongly in the outcome.
None of those automatically demonstrate that there is a defined buyer, the problem is sufficiently urgent, someone has budget, there is a repeatable buying process, the proposition converts, the economics work, or customers will buy consistently.
Commercialisation is the process of turning technical capability into a commercial model that can be repeated.
The signals
The market is engaging, but it is difficult to distinguish curiosity from intent.
Pilots and PoCs happen, but they do not consistently become commercial relationships.
The technology could solve multiple problems for multiple customer types, making it difficult to choose where to focus.
Relationships, discovery, demos, follow-up and judgement still rely disproportionately on the founder.
There are opportunities in the CRM, but qualification, next steps and probability are unclear.
Work is happening, but it is difficult to explain why something worked or reliably reproduce it.
Fit
Narrow is unlikely to be the right fit if:
Does this sound like where the business is?